Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 9/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | AR | P10275 | 1/20 | 0.34 |
| ▸ | EGFR | P00533 | 7/20 | 0.33 |
| ▸ | PLK4 | O00444 | 2/20 | 0.33 |
| ▸ | CDK9 | P50750 | 1/20 | 0.33 |
| ▸ | BTK | Q06187 | 3/20 | 0.32 |
| ▸ | ITK | Q08881 | 1/20 | 0.32 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.31 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.31 |
| ▸ | IRAK3 | Q9Y616 | 1/20 | 0.31 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30297836 | 0.91 | CRBN (0.42) | CRBNESR1AREGFRPLK4 | |
| SCHEMBL24421155 | 0.91 | CRBN (0.42) | CRBNESR1AREGFRPLK4 | |
| SCHEMBL24421474 | 0.90 | CRBN (0.39) | CRBNESR1AREGFRPLK4 | |
| SCHEMBL24421451 | 0.87 | CRBN (0.38) | CRBNESR1AREGFRPLK4 | |
| SCHEMBL24421179 | 0.87 | CRBN (0.40) | CRBNESR1AREGFRCDK9 | |
| SCHEMBL24421568 | 0.86 | CRBN (0.37) | CRBNESR1AREGFRPLK4 | |
| SCHEMBL24420813 | 0.83 | CRBN (0.46) | CRBNESR1AREGFRPLK4 | |
| SCHEMBL30297830 | 0.83 | CRBN (0.46) | CRBNESR1AREGFRPLK4 | |
| SCHEMBL24421103 | 0.83 | CRBN (0.33) | CRBNESR1EGFRIRAK1IRAK4 | |
| SCHEMBL24421025 | 0.81 | CRBN (0.47) | CRBNESR1AREGFRPLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022099117-A1 | BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE | PRELUDE THERAPEUTICS INCORPORATED (US) | 2022-05-12 | — | — | WO | disclosed |